In 2024, the U.S. Drug Enforcement Administration (DEA) indicated which they intend to reclassify cannabis to be a Plan III drug. This rescheduling will recognize that cannabis has authentic professional medical needs and may help open up the door to research on other potential treatment method uses. That is for https://thcaguides23332.educationalimpactblog.com/56820868/euphoria-inducing-substances-for-dummies